[Anti-hemophilia drugs: from cryoprecipitate to factor VIII concentrates of high purity].
The methods have been surveyed concerning the isolation of concentrates of the factor VIII which are the drugs used in treatment of a hereditary disease--hemophilia. Prospects of improvement of these drugs have been considered, their characteristics (activity, purity, method of virus inactivation) are presented that permits one to orientate himself in a wide assortment of drugs, as well as to choose the concrete drug to be used in clinic.